PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsrEVO Biologics
rEVO Biologics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AtrynAntithrombin alfa2009-02-06
Antithrombin iii deficiency
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Antithrombin alfa
congenital heart defects
,
postoperative hemorrhage
,
healthy volunteers/patients
,
renal dialysis
,
covid-19
,
sepsis
,
liver cirrhosis
,
syndrome
,
liver failure
,
hepatic insufficiency
,
thromboembolism
,
cardiac surgical procedures
,
reperfusion injury
,
coronary artery bypass
,
respiratory distress syndrome
,
severe acute respiratory syndrome
,
acute lung injury
,
newborn respiratory distress syndrome
,
hepatic veno-occlusive disease
,
end stage liver disease
,
fibrosis
,
acute-on-chronic liver failure
,
wounds and injuries
,
blood coagulation disorders
,
hemostatic disorders
,
venous thrombosis
,
cardiopulmonary bypass
,
disseminated intravascular coagulation
,
venous thromboembolism
,
hemorrhage
,
extracorporeal membrane oxygenation
,
menopause
,
critical illness
,
coronary artery disease
,
percutaneous coronary intervention
,
dual anti-platelet therapy
,
antithrombin iii deficiency
,
thrombosis
,
hemophilia a
,
thrombophilia
,
pre-eclampsia
,
myocardial infarction
,
infarction
,
acute coronary syndrome
,
aortic valve stenosis
,
aortic valve insufficiency
,
mitral valve insufficiency
,
mitral valve stenosis
,
toxemia
,
coagulation protein disorders
,
congenital disorders of glycosylation
,
leukemia
,
atrial fibrillation
,
embolic stroke
,
recurrence
,
multiple sclerosis
,
relapsing-remitting multiple sclerosis
,
sclerosis
,
sickle cell anemia
,
hemolysis
,
hemolytic anemia
,
heart failure
,
thrombocytopenia
,
environmental biomarkers
,
postmenopause
,
cicatrix
,
burns
,
factor xiii deficiency
,
migraine disorders
,
acute-phase reaction
,
antiphospholipid syndrome
,
malnutrition
,
fatal outcome
,
cytokine release syndrome
,
septic shock
,
upper extremity deep vein thrombosis
,
nephritis
,
transfusion reaction
,
liver transplantation
,
heart diseases
,
heart septal defects
,
pancreatitis
,
acute kidney injury
,
portal hypertension
,
embolism
,
budd-chiari syndrome
,
chronic renal insufficiency
,
post-acute covid-19 syndrome
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
hip fractures
,
chronic kidney failure
,
renal insufficiency
,
hemodiafiltration
Benzocaine
renal insufficiency
,
lymphoma
,
t-cell lymphoma
,
immunoblastic lymphadenopathy
,
enteropathy-associated t-cell lymphoma
,
t-cell lymphoma peripheral
,
heart diseases
,
neuroendocrine tumors
,
carcinoid tumor
,
malignant carcinoid syndrome
,
carcinoid heart disease
,
serotonin syndrome
Serine
covid-19
,
pneumonia
,
inflammation
Bevifimod
macular edema
,
macular degeneration
,
choroidal neovascularization
,
refractive errors
,
myopia
,
astigmatism
,
hyperopia
,
contact lenses
,
hypertension
,
ocular hypertension
,
glaucoma
,
open-angle glaucoma
Nadide
peripheral nervous system diseases
,
diabetic neuropathies
Crystalloid
fibromyalgia
,
iron deficiencies
,
restless legs syndrome
,
heart failure
,
iron-deficiency anemia
,
neoplasms
,
anemia
Rfviia
hemophilia a
,
hemophilia b
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use